BackForward Pharma A/S Overview

Forward Pharma A/S Other Current Liabilities

Track Forward Pharma A/S's other current liabilities ($0) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Other Current Liabilities
$0.00

Peer average

Loading

Forward Pharma A/S Other Current Liabilities History

Loading

Forward Pharma A/S vs. peers: Other Current Liabilities Comparison

Loading

Forward Pharma A/S Other Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Forward Pharma A/S (FWP) FAQ

Forward Pharma A/S's other current liabilities stands at $0 as of November 2022. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Open the history chart to see whether Forward Pharma A/S's other current liabilities is expanding or contracting. Sustained growth in other current liabilities can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.

The history chart shows how Forward Pharma A/S's other current liabilities evolved across reporting periods, while the comparison chart places FWP next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Healthcare, other current liabilities is commonly used to spot outliers. Forward Pharma A/S's reading of $0 is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.